- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03551314
Effects of Two Modalities of Non-invasive Ventilation After Extubation in Very Low Birth Weight Neonates
Effects of Two Modalities of Non-invasive Ventilation on Breathing Pattern Variables of Preterm Neonates of Very Low Weight After Extubation
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Minas Gerais
-
Belo Horizonte, Minas Gerais, Brazil, 30130-100
- Hospital das Clinicas da Ufmg
-
Belo Horizonte, Minas Gerais, Brazil, 31270-901
- Laboratório de Avaliação e Pesquisa em Desempenho Cardiorrespiratório da UFMG
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Presented gestational age less than or equal to 32 weeks and weight less than or equal to 1,500 g;
- Stability from an hemodynamic point of view (without use of amines);
- Have undergone invasive mechanical ventilation;
- Absence of congenital heart diseases and / or other congenital anomalies (myelomeningocele, gastroschisis and / or omphalocele) or chromosomal abnormalities;
- Absence of any condition that requires surgery in the neonatal period.
Exclusion Criteria:
- Presented air leak syndrome (pneumothorax, pneumomediastinum); upper airway obstruction after extubation and non-scheduled extubation.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Nasal Intermittent Positive Pressure
In this group, soon after extubation, the newborns will be studied initially in NIPPV for one hour. Infants will be studied in supine while in their incubator. NIPPV: Nasal Intermittent Positive Pressure Ventilation |
- NIPPV The following parameters: inspiratory pressure = 15 cmH2O / final expiratory positive pressure = 6 cmH2O / inspiratory time = 0.40 / flow = 6-8 L.min-1 / respiratory rate = 24. Respiratory inductive plethysmography is used to evaluate breathing pattern (tidal volume, respiratory rate, minute ventilation, mean inspiratory flow) and chest wall motion (labor breathing index - LBI, phase relation in inspiratory breathing - PhRIB, phase relation in expiratory breathing - PhREB, total phase relation - PhRTB and phase angle). |
Active Comparator: Continuous Positive Airway Pressure
In this group, soon after extubation, the newborns will be studied initially in CPAP for one hour. Infants will be studied in supine while in their incubator. CPAP: Continuous Positive Airway Pressure |
- CPAP The following parameters: pressure of 6 cmH2O, with flow of 6-8L/min. Respiratory inductive plethysmography is used to evaluate breathing pattern (tidal volume, respiratory rate, minute ventilation, mean inspiratory flow) and chest wall motion (labor breathing index - LBI, phase relation in inspiratory breathing - PhRIB, phase relation in expiratory breathing - PhREB, total phase relation - PhRTB and phase angle). |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Tidal volume
Time Frame: Measure during the two non-invasive ventilation strategies. Tidal volume will be measured for 2 hours, one hour in continuous positive airway pressure and one hour in nasal intermittent positive pressure ventilation.
|
Defined as the volume of air entering or exiting the lungs during each breath - in millilitres.
|
Measure during the two non-invasive ventilation strategies. Tidal volume will be measured for 2 hours, one hour in continuous positive airway pressure and one hour in nasal intermittent positive pressure ventilation.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Respiratory rate
Time Frame: Measure during the two non-invasive ventilation strategies. Respiratory rate will be measured for 2 hours, one hour in continuous positive airway pressure and one hour in nasal intermittent positive pressure ventilation.
|
Breaths per minute
|
Measure during the two non-invasive ventilation strategies. Respiratory rate will be measured for 2 hours, one hour in continuous positive airway pressure and one hour in nasal intermittent positive pressure ventilation.
|
Minute ventilation
Time Frame: Measure during the two non-invasive ventilation strategies. Minute ventilation will be measured for 2 hours, one hour in continuous positive airway pressure and one hour in nasal intermittent positive pressure ventilation.
|
Computed from tidal volume multiplied by respiratory rate, in liters/minute
|
Measure during the two non-invasive ventilation strategies. Minute ventilation will be measured for 2 hours, one hour in continuous positive airway pressure and one hour in nasal intermittent positive pressure ventilation.
|
Mean inspiratory flow
Time Frame: Measure during the two non-invasive ventilation strategies. Mean inspiratory flow will be measured for 2 hours, one hour in continuous positive airway pressure and one hour in nasal intermittent positive pressure ventilation.
|
Is a estimation of respiratory center drive activity.
The higher its value, the greater the drive and vice-versa.
|
Measure during the two non-invasive ventilation strategies. Mean inspiratory flow will be measured for 2 hours, one hour in continuous positive airway pressure and one hour in nasal intermittent positive pressure ventilation.
|
Labored Breathing Index (LBI)
Time Frame: Measure during the two non-invasive ventilation strategies. Labor breathing index (LBI) will be measured for 2 hours, one hour in continuous positive airway pressure and one hour in nasal intermittent positive pressure ventilation.
|
This is a measure of chest wall coordination.
This is the Labored Breathing Index (LBI) of a breath that takes into account phase and amplitude of the ribcage and abdomen traces.
It is computed as the ratio of the sum of the integrals of the absolut values of the derivatives of the inspiratory limbs of ribcage and abdomen excursions divided by the corresponding integral of the derivative of the inspiratory limb of the tidal volume deflection.
This measure of thoracoabdominal coordination is computed on a breath by breath basis.
Perfect thoracoabdominal coordination produces an LBI of 1.0.
In babies or adults who are relaxed and awake or in Quiet State, LBI lies between 1.0 and 1.2 but no systematic study of the normal values of LBI as a function of sleep stage and body posture has yet been undertaken.
In Active State, thoracoabdominal discoordination generally is associated with elevated LBI values.
|
Measure during the two non-invasive ventilation strategies. Labor breathing index (LBI) will be measured for 2 hours, one hour in continuous positive airway pressure and one hour in nasal intermittent positive pressure ventilation.
|
Phase relation in inspiratory breathing (PhRIB)
Time Frame: Measure during the two non-invasive ventilation strategies. Phase relation in inspiratory breathing will be measured for 2 hours, one hour in continuous positive airway pressure and one hour in nasal intermittent positive pressure ventilation.
|
This express the percentage agreement between direction of ribcage and abdomen movements during the inspiratory phase of breath.
|
Measure during the two non-invasive ventilation strategies. Phase relation in inspiratory breathing will be measured for 2 hours, one hour in continuous positive airway pressure and one hour in nasal intermittent positive pressure ventilation.
|
Phase relation in expiratory breathing
Time Frame: Measure during the two non-invasive ventilation strategies. Phase relation in expiratory breathing will be measured for 2 hours, one hour in continuous positive airway pressure and one hour in nasal intermittent positive pressure ventilation.
|
This express the percentage agreement between direction of ribcage and abdomen movements during the expiratory phase of breath.
|
Measure during the two non-invasive ventilation strategies. Phase relation in expiratory breathing will be measured for 2 hours, one hour in continuous positive airway pressure and one hour in nasal intermittent positive pressure ventilation.
|
Phase relation in total breathing
Time Frame: Measure during the two non-invasive ventilation strategies. Phase relation in total breathing will be measured for 2 hours, one hour in continuous positive airway pressure and one hour in nasal intermittent positive pressure ventilation.
|
This express the percentage agreement between direction of ribcage and abdomen movements during the entire breath cycle.
|
Measure during the two non-invasive ventilation strategies. Phase relation in total breathing will be measured for 2 hours, one hour in continuous positive airway pressure and one hour in nasal intermittent positive pressure ventilation.
|
Phase angle
Time Frame: Measure during the two non-invasive ventilation strategies. Phase angle will be measured for 2 hours, one hour in continuous positive airway pressure and one hour in nasal intermittent positive pressure ventilation.
|
The phase angle is computed from Lissajous loops between ribcage and abdomen excursions on a breath by breath basis.
|
Measure during the two non-invasive ventilation strategies. Phase angle will be measured for 2 hours, one hour in continuous positive airway pressure and one hour in nasal intermittent positive pressure ventilation.
|
Collaborators and Investigators
Investigators
- Principal Investigator: Verônica F Parreira, PhD, Federal University of Minas Gerais
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CAAE: 67787917.7.0000.5149
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Preterm Infant
-
Duke UniversityNational Institute of Nursing Research (NINR)CompletedPreterm Infant Development | Preterm Infant Health
-
Christiana Care Health ServicesCompletedInfant | Infant, Premature | Infant, Preterm | Infant, LateUnited States
-
Medical University of GrazCompleted
-
NICHD Neonatal Research NetworkEunice Kennedy Shriver National Institute of Child Health and Human Development...CompletedInfant, Newborn | Infant, Moderate PretermUnited States
-
NICHD Neonatal Research NetworkEunice Kennedy Shriver National Institute of Child Health and Human Development...CompletedInfant, Newborn | Infant, Moderate PretermUnited States
-
University of OxfordShoklo Malaria Research UnitCompleted
-
yangjieCompletedOutcome, Fatal | Preterm Infant | Morbidity;Infant
-
Medical University of GrazCompletedIntubation; Difficult or Failed | Preterm Infant | Term InfantAustria
-
IRCCS Azienda Ospedaliero-Universitaria di BolognaCompletedPreterm Birth | Cerebral Autoregulation | Premature Infant DiseaseItaly
-
Nantes University HospitalCompleted
Clinical Trials on Nasal Intermittent Positive Pressure
-
Daping Hospital and the Research Institute of Surgery...Unknown
-
Hospital Israelita Albert EinsteinFundação de Amparo à Pesquisa do Estado de São PauloUnknownRespiratory Distress SyndromeBrazil
-
Instituto Materno Infantil Prof. Fernando FigueiraCompletedRespiratory Distress Syndrome | PrematurityBrazil
-
Rambam Health Care CampusCompletedVentilator Lung; NewbornIsrael
-
Women and Infants Hospital of Rhode IslandUnknownRespiratory Distress Syndrome | Apnea of Prematurity | PrematurityUnited States
-
University of FlorenceCompleted
-
University of UtahActive, not recruitingRespiratory Failure | Respiratory Insufficiency | Respiratory Distress Syndrome in Premature Infant | Infant,PrematureUnited States
-
Carmel Medical CenterRecruiting
-
Virginia Commonwealth UniversityTerminatedLow Birth Weight | Noninvasive VentilationUnited States
-
University of ManitobaHealth Sciences Centre Foundation, ManitobaCompletedApnea | Bronchopulmonary Dysplasia | Infant, PrematureCanada